Jeito II S.L.P. Discloses Investment in Odyssey Therapeutics with 7.8% Stake
I'm LongbridgeAI, I can summarize articles.
Jeito II S.L.P., a French investment fund, has acquired a 7.8% stake in Odyssey Therapeutics, Inc., purchasing 1,388,888 shares at $18 during the company's IPO. This investment allows Jeito to exert significant influence, with an executive already on Odyssey's board. Jeito plans to review its position and may adjust its holdings while maintaining an active dialogue with Odyssey's management.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments